Home Tags Medicine
medicine Related Content
The NHS could save £300 million over the next 3 years as Phase 4 of the Electronic Prescription Service (EPS) is rolled out across the country.
Cosmo Feilding Mellen, Managing Director of Spectrum Therapeutics UK looks at access to medical cannabis and to what extent is medical cannabis now legalised.
After a career spanning more than 20 years, a Swansea University Professor’s passion for research is as ‘strong as ever’, as he marks a very notable achievement – the release of his 100th cancer research paper.
In the second of a series of five articles, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine.
Using cross-disciplinary technology, Dr Kunio Matsumoto, PhD, Professor at Kanazawa University in Japan is extending research on growth factor toward synthetic biologics for regeneration-based medicine and cancer theranostics.
Hemp Mongolia LLC reveals its implementation plan to build the largest hemp processing farm in the Central Asian steppes.
Brendan Crossey, Chief Executive Officer of Healthcare Analytics Limited, directs our thoughts to innovative bed tracking at the Northern Health and Social Care Trust, one of five health and social care trusts in Northern Ireland.
GreenLight Medicines is a supplier of quality supplements and is an active MedCan research company GreenLight, Supplements and Medicines.
Ahead of World Hepatitis Day on 28th July 2019, the WHO Regional Office for Africa detail the key issues when it comes to the burden of viral hepatitis in the WHO Region of Africa.
Here, General Manager Bart den Hertog, introduces MariPharm, the world’s first medicinal cannabis business, highlighting the company’s major milestone moments, its clinical trial process and recommended product dosage.
Of the digitisation projects ongoing at St Helens and Knowsley Teaching Hospitals (STHK) NHS Trust, electronic prescribing and medicines administration (EPMA) represents the biggest step forward for patient safety.
In this article, several authors discuss the integration of in vivo imaging and mathematical modelling in nanoparticle pharmacokinetics.
A new £2.6 million project led by Swansea University Medical School aims to dramatically improve the diagnosis and treatment of ovarian cancer.
Redefining efficiency based on what matters to cancer patients is placed under the spotlight here by All.Can, including identifying opportunities for change.
John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.
Scientists have determined a new way to protect the hair follicle from chemotherapy in an effort to prevent hair loss as a result of cancer treatments.
Today (12 September) the NHS Confederation responded to the publication of Operation Yellowhammer, a document describing alarming food and medicine shortages after Brexit.
In this interview, Jean-Marie Dangou from the WHO Regional Office for Africa discusses diabetes in the African region, including lack of access to treatment and ongoing action to solve this.
PillTime Ltd highlights the importance of medication management for diabetes as it remains a significant burden on the NHS.
Simon Manthorpe, CEO of EOS Scientific, explains why CBD oil could be the answer for a calming solution to Seasonal Affective Disorder.